Shi Shi Pharmaceutical Group (2005) reported interim profit attributable to shareholders of about RMB 320 million for the six months ended June 30, 2026, up 12.99% year on year, according to Ming Pao.

Basic earnings per share were RMB 0.1107, an increase of 15.07% from a year earlier. The company declared an interim dividend of HK$0.055 per share, compared with HK$0.05 a year ago.